Caricamento...
Receptor-Directed Therapy of T-Cell Leukemias and Lymphomas
T-Cell leukemias and lymphomas represent a less common and heterogeneous group of lymphoid neoplasms. Overall, they respond less well to chemotherapy and have a poorer prognosis than their B-cell counterparts. T-Cell tumors express a number of potential targets for receptor-directed antibody therapy...
Salvato in:
| Pubblicato in: | J Immunotoxicol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243878/ https://ncbi.nlm.nih.gov/pubmed/18569395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15476910802129661 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|